The Monkey Drug Trials were a series of controversial experiments conducted in the late 1960s and early 1970s, primarily by psychologist Dr. Deneau and his colleagues at the University of Michigan. The primary aim of these trials was to investigate the self-administration of drugs, specifically addictive substances, by non-human primates such as monkeys and chimpanzees.

During the experiments, monkeys were placed in specially designed cages and trained to self-administer drugs such as cocaine, heroin, morphine, and amphetamines. The drugs were typically delivered intravenously, with the monkeys learning to press a lever that would inject the substance into their bloodstream. As the trials progressed, the monkeys were given unlimited access to the drugs, allowing them to self-administer as much as they desired.

The Monkey Drug Trials produced several significant findings, with many of the monkeys developing strong drug-seeking behaviors, addiction, and in some cases, overdose. The results of the trials demonstrated that non-human primates were capable of developing patterns of drug use that were similar to those observed in human addiction, providing valuable insights into the biological and behavioral aspects of substance abuse.

However, the experiments were met with widespread criticism due to the ethical concerns surrounding the treatment of the animals. Opponents of the trials argued that the monkeys suffered severe physical and psychological harm, which raised questions about the morality of such research. As a result, the Monkey Drug Trials remain a controversial subject in the history of addiction research and animal experimentation.

свернуть